GO
Loading...

Market Outlook

More

  • Map Out Your Second Half Game Plan   Tuesday, 2 Jul 2013 | 7:08 AM ET
    Map Out Your Second Half Game Plan

    Mark Luschini, Janney Montgomery Scott, and David Darst, Morgan Stanley Wealth Management, provide their investment strategies for the next six months, as the markets face a slew of challenges, including a possible pullback in the Fed's asset-buying program.

  • Can You Spot Next Quarter's Winners & Loser?   Tuesday, 2 Jul 2013 | 6:40 AM ET
    Can You Spot Next Quarter's Winners & Loser?

    Ashwani Kaul, Kaul Advisory Group, provides his projections on which sectors will likely prove to be the real earnings bright spots in the second quarter.

  • Market Bears Eye Jobs, Rates & Housing   Tuesday, 2 Jul 2013 | 6:32 AM ET
    Market Bears Eye Jobs, Rates & Housing

    Tim Holland, TAMRO Capital, provides a preview of Friday's employment report and weighs in on how Fed policy will likely impact the markets.

  • Pre-Market Report: Zynga Names New CEO   Tuesday, 2 Jul 2013 | 6:01 AM ET

    CNBC's Ross Westgate tells you what the markets will be watching as we approach the start of trading in the U.S.

  • Markets Begin Second Half of the Year   Monday, 1 Jul 2013 | 7:00 PM ET
    Markets Begin Second Half of the Year

    Are the markets in a super-bull cycle? Liz Ann Sonders, Charles Schwab; Jeff Kilburg, KKM Financial; Jeremy Siegel, Wharton Finance professor; and Zane Brown, Lord Abbett, share their opinions.

  • No Huddle Offense: Onyx Rejects Bid By Amgen   Monday, 1 Jul 2013 | 6:58 PM ET
    No Huddle Offense: Onyx Rejects Bid By Amgen

    Mad Money host Jim Cramer shares his final thoughts of the day.

  • You Ask, Cramer Answers! Biotech Check-Up   Monday, 1 Jul 2013 | 6:45 PM ET
    You Ask, Cramer Answers! Biotech Check-Up

    Catching up on biotech stocks Trius Therapeutics, Array Biopharma and Cytokinetics, with Mad Money host Jim Cramer.

  • Onyx rejects $10 billion bid From Amgen   Monday, 1 Jul 2013 | 6:25 PM ET
    Onyx Rejects $10 Billion Bid From Amgen

    Onyx Pharmaceuticals is seeking out more competitive offers beyond Amgen's $10 billion takeover bid. "Mad Money" host Jim Cramer says there are better opportunities in the biotech space right now.

  • Noodles & Co. Debuts on the Nasdaq   Monday, 1 Jul 2013 | 6:15 PM ET
    Noodles & Co. Debuts on the Nasdaq

    Casual restaurant Noodles & Co. currently operates 343 restaurants, 52 of which are franchised. Mad Money host Jim Cramer says the company is very well run, but that investors should wait for a market pullback before buying.

  • Profit From Today's Action   Monday, 1 Jul 2013 | 6:00 PM ET
    Profit From Today's Action

    Mad Money host Jim Cramer takes viewers behind the scenes of today's market rally.

  • You Tweet It, We Trade It!   Monday, 1 Jul 2013 | 5:50 PM ET
    You Tweet It, We Trade It!

    "Fast Money" traders explains why he has moved on from Louisiana-Pacific; and how to play Sirius XM Radio and other stocks requested on Twitter.

  • Constellation Brands Earnings Out Tomorrow   Monday, 1 Jul 2013 | 5:45 PM ET
    Constellation Brands Earnings Out Tomorrow

    Fast forwarding to Tuesday's trades, with the "Fast Money" traders. June auto sales data is out tomorrow, and Constellation Brands will reports its Q1 earnings.

  • Gartman: Gold Goes Higher From Here   Monday, 1 Jul 2013 | 5:40 PM ET
    Gartman: Gold Goes Higher From Here

    Gold posted its sharpest quarterly decline on record in Q2. Dennis Gartman of The Gartman Letter, explains why he is bullish on the commodity; and Harvey Kanter, Blue Nile CEO, discusses how jewelry retailers are faring amid falling prices.

  • Onyx Rejects Takeover Offer   Monday, 1 Jul 2013 | 5:15 PM ET
    Onyx Rejects Takeover Offer

    The emerging markets ETF is continuing its impressive 5-day winning streak, with the "Fast Money" traders; Barbara Ryan, FTI Consulting, discusses Onyx Pharmaceuticals' decision to reject a bid from Amgen, and opportunities in the biotech industry now.

  • Tomorrow In :30   Monday, 1 Jul 2013 | 4:53 PM ET
    Tomorrow In :30

    Eyeing Tuesday's trading session, with Michael Underhill, Capital Innovations CIO; Chris Lecerenza, Russell & Co.; and Oliver Pursche, Gary Goldberg Financial Services.

  • Buy Gold or Stocks?   Monday, 1 Jul 2013 | 4:15 PM ET
    Buy Gold or Stocks?

    Breaking down the factors affecting gold and stocks, with James Rickards of Tangent Capital and Lee Munson of Portfolio Asset Management.

  • Market's Next Step   Monday, 1 Jul 2013 | 4:03 PM ET
    Market's Next Step

    Can the strong rally continue in the second half? Danielle Hughes of Divine Capital, Erik Ristuben at Russell Investments, Wasif Latif at USAA Investments and CNBC's Rick Santelli discuss.

  • Commodities Tomorrow: Gold Rebounds   Monday, 1 Jul 2013 | 4:00 PM ET
    Commodities Tomorrow:

    CNBC's Sharon Epperson discusses the day's activity in the commodities markets. Gold rebounded today, and copper was up, as well.

  • Markets Start Q3 Strong   Monday, 1 Jul 2013 | 3:53 PM ET
    Markets Start Q3 Strong

    Dissecting today's market action ahead of the close, with Brian Belski, BMO Capital Markets, and Chris Hyzy, U.S. Trust.

  • Fed, Stimulus & the Markets   Monday, 1 Jul 2013 | 3:13 PM ET
    Fed, Stimulus & the Markets

    Is the Fed overestimating the strength of the U.S. consumer? Dean Baker, Center For Economic and Policy Research; Andrew Wilkinson, Miller Tabak & Co.; and CNBC's Rick Santelli, discuss.